Vous êtes sur la page 1sur 44




The Himalaya Drug Company is a company established by M Manal in 1930 and based
in Bangalore, India. It produces health care products under the name Himalaya Herbal
Healthcare whose products include Ayurveda ingredients. It is spread across locations in India,
the United States, the Middle East, Asia and Europe, while its products are sold in 92 countries
across the world.

The company was founded in 1930 by Mr. Manal with a clear vision that they want to serve
society by bringing Ayurvedic products.Company staterd its operations in Dehradun way back in
the 1930s, the company later spread its wings to MUMBAI.

In 1975, the company set up an advanced manufacturing facility in Makali, Bangalore, India,
which today houses the Corporate headquarters.In 1991, the company relocated its R&D facility
to Bangalore.The Himalaya Drug Company manufactures and markets herbal healthcare and
personal care products to customers worldwide. It offers pharmaceuticals for children's,
women's, men's, general, oral, and derma healthcare aspects; nutrition and animal health
products; personal care products, including skin care, hair care, oral care, herbal tea, specialty,
and men's care products; and wellness products. The company provides baby care products, such
as pre-bath, bath, and post-bath products; and baby kits and diapers.

Himalaya carries an ISO 9001 certification, the most rigorous ISO conformance standard, for
excellence in manufacturing as established by the International Organization for Standardization.
Himalaya products combine the rich value of an old system of natural medicine with all the
processes of modern pharmaceutical technology including scientific assessment of efficacy
through primary clinical research, Good Manufacturing Practices and quality controls using
sophisticated chromatographic "fingerprinting" techniques. Himalaya products contain herbs
grown by the Himalaya Drug Company. For more information

To analyze the clear cut picture about a company regarding finance, marketing,
human resource policies of the company.
To know the units of Himalaya drug company all over the world.
To know about the present situations in the company


To identify the company position in present market

To study the industrial and company profile of Himalaya drug company
To know the strengths, weakness and opportunities and threats of Himalaya drug
To know about corporate social responsibility activities of Himalaya drug company
To know about the competitors of Himalaya drug company.


The scope of the study is to deal &discuss growth of the company in worldwide and its
diversification and recent development. It also help to analyze present and future trend along
with industry market size, market prospects and its impact on company.


The study was conducted based on the secondary sources of the data collection.
The progress of the sector was analyze at a glance keeping into view the
performance of various market player.
All the percentages and figures related to the sector are gathered form secondary
source like web sites and different portals.
To analysis the data we use both quality and quantitative tools like graph and
SWOT analysis.


Time limit is the main barrier of the study.
Maximum secondary data is taken.
These are made on certain assumptions.
Financial information isnt mentioned in this study



The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth
largest in terms of value, as per a report by Equity Master. India is the largest provider of generic
drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of
volume. Of late, consolidation has become an important characteristic of the Indian
pharmaceutical market as the industry is highly fragmented.

India enjoys an important position in the global pharmaceuticals sector. The country also has a
large pool of scientists and engineers who have the potential to steer the industry ahead to an
even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat
AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

The UN-backed Medicines Patent Pool has signed six sub-licences with Aurobindo, Cipla,
Desano, Emcure, Hetero Labs and Laurus Labs, allowing them to make generic anti-AIDS
medicine TenofovirAlafenamide (TAF) for 112 developing countries.

Market Size:

The Indian pharma industry, which is expected to grow over 15 per cent per annum between
2015 and 2020, will outperform the global Parma industry, which is set to grow at an annual rate
of 5 per cent between the same periods. The market is expected to grow to US$ 55 billion by
2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size, as
stated by Mr.Arun Singh, Indian Ambassador to the US. Branded generics dominate the
pharmaceuticals market, constituting nearly 80 per cent of the market share (in terms of

India has also maintained its lead over China in pharmaceutical exports with a year-on-year
growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16, according to data from the
Ministry of Commerce and Industry. In addition, Indian pharmaceutical exports are poised to
grow between 8-10 per cent in FY 2016-17. Imports of pharmaceutical products rose marginally
by 0.80 per cent year-on-year to US$ 1,641.15 million.

Overall drug approvals given by the US Food and Drug Administration (USFDA) to Indian
companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-15. The country
accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80
billion US generics market.

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture,

bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent
a year and reach US$ 100 billion by 2025. Bophirima, comprising vaccines, therapeutics and
diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs
12,600 crore (US$ 1.89 billion).

Some of the major investments in the Indian pharmaceutical sector are as follows:


The Union Cabinet has given its nod for the amendment of the existing Foreign Direct
Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent
under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 14.53 billion
between April 2000 and December 2016, according to data released by the Department of
Industrial Policy and Promotion (DIPP). Piramal Enterprises Ltd acquired a portfolio of
spasticity and pain management drugs from UK-based specialty biopharmaceutical company
Mallinckrodt Pharmaceuticals, in an all-cash deal for Rs1,160 crore (US$ 171 million).
AurobindoPharma has bought Portugal based Generis Farmaceutica SA, a generic drug
company, for EUR 135 million (US$ 144 million).
Sun Pharmaceutical Industries Ltd, India's largest drug maker, has entered into an agreement
with Switzerland-based Novartis AG, to acquire the latters branded cancer drug Odomzo for
around US$ 175 million.
Kedaara Capital Advisors LLP, a private equity (PE) firm, plans to invest Rs 430 crore (US$
64.5 million) to acquire a minority stake in Hyderabad-based diagnostics chain Vijaya Diagnostic
Centre Pvt Ltd.

Sun Pharmaceuticals Industries Limited plans to acquire 85.1 per cent stake in Russian
company Biosintez for US$ 24 million for increasing its presence in Russia through local
manufacturing capability.
Abbott Laboratories, a global drug maker based in US, plans to set up an innovation and
development center (I&D) in Mumbai, which will help in developing new drug formulations,
new indications, dosing, packaging and other differentiated offerings for Abott's global branded
generics business.
Indias largest drug maker Sun Pharmaceutical Industries Limited has entered into a
distribution agreement with Japan's Mitsubishi Tanabe Pharma Corporation to market 14
prescription brands in Japan.
Syngene International Limited will be setting up its fourth exclusive Research and
Development (R&D) center named Syngene Amgen Research and Development Center (SARC)
for a US-based biotechnology company Amgen Incorporation in Bengaluru.
Indias third largest drug maker Lupin Limited plans to file its first biosimilarEtanercept for
approval in Japan, worlds second largest drug market, in 2017.
Rubicon Research Pvt Ltd, a contract research and manufacturing services firm, is in advanced
talks with Everstone Capital and a few high-net-worth Individuals (HNI) to raise up to Rs 240
crore (US$ 36 million), which will be used to increase the companys manufacturing capabilities.
Lupin Ltd plans to acquire a portfolio of 21 generic brands from Japan-based Shionogi & Co
Ltd for Rs 10.08 billion (US$ 151.2 million), which will help to strengthen its presence in the
worlds second largest pharmaceutical market.
International Finance Corporation (IFC), the investment arm of the World Bank, plans to invest
upto US$ 75 million in Glenmark, which is looking to raise around US$ 200 million for
expansion and the launch of several new products in India and other emerging markets over the
next three years.
Cipla Limited plans to invest around Rs 600 crore (US$ 90 million) to set up a biosimilar
manufacturing facility in South Africa for making affordable cancer drugs and growing its
presence in the market.
RusanPharma, a firm which specialises in de-addiction and pain management products, plans to
invest Rs 100 crore (US$ 15 million) in a R&D centre and a manufacturing unit in Kandla,
located in Kutch District in Gujarat.

The Medicines Patent Pool (MPP) has signed a licencing agreement with six Indian drug
makers for the generic manufacturing of four antiretrovirals (ARV) and hepatitis C direct-acting
antiviral drug Daclatasvir.
Dr Reddy's Laboratories, one of the major pharmaceutical companies of India, has entered into
a strategic collaboration agreement with Turkey-based TR-Pharm, to register and subsequently
commercialise three biosimilar products in Turkey.
Lupin has completed the acquisition of US-based GAVIS Pharmaceuticals in a deal worth US$
880 million, which is expected to enhance its product pipeline in dermatology, controlled
substances and high-value speciality products.
Cipla Ltd, one of the major pharmaceutical and biotechnology companies in India, has acquired
two US-based generic drug makers, InvaGen Pharmaceuticals Inc. and Exelan Pharmaceuticals
Inc., for US$ 550 million, which is expected to strengthen Cipla's US business.
Emcure Pharmaceuticals has acquired Canada's International Pharmaceutical Generics Ltd and
its marketing arm Marcan Pharmaceuticals in order to boost its global expansion drive.
Cipla announced the acquisition of two US-based companies, InvaGen Pharmaceuticals Inc.
and Exelan Pharmaceuticals Inc., for US$550 million.
Glaxosmithkline Pharmaceuticals has started work on its largest greenfield tablet
manufacturing facility in Vemgal in Kolar district, Karnataka, with an estimated investment of Rs
1,000 crore (US$ 150 million).
Lupin has acquired two US based pharmaceutical firms, Gavis Pharmaceuticals LLC and Novel
Laboratories Inc, in a deal worth at US$ 880 million.
Several online pharmacy retailers like PharmEasy, Netmeds, Orbited, are attracting investments
from several investors, due to double digit growth in the Rs 97,000 crore ( US$ 14.55 billion)
Indian pharmacy market.
StelisBiopharma announced the breakthrough construction of its customized, multi-product,
biopharmaceutical manufacturing facility at Bio-Xcell Biotechnology Park in Nusajaya, Johor,
Malaysia's park and ecosystem for industrial and healthcare biotechnology at a total project
investment amount of US$ 60 million.

Strides Arcolab entered into a licensing agreement with US-based Gilead Sciences Inc to
manufacture and distribute the latter's cost-efficient TenofovirAlafenamide (TAF) product to treat

HIV patients in developing countries. The licence to manufacture Gilead's low-cost drug extends
to 112 countries.

Government Initiatives

The Government of India unveiled 'Pharma Vision 2020' aimed at making India a global leader
in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost
investments. Further, the government introduced mechanisms such as the Drug Price Control
Order and the National Pharmaceutical Pricing Authority to deal with the issue of affordability
and availability of medicines.

MrAnanth Kumar, Union Minister of Chemicals and Petrochemicals, has announced setting up
of chemical hubs across the country, early environment clearances in existing clusters, adequate
infrastructure, and establishment of a Central Institute of Chemical Engineering and Technology.

Some of the major initiatives taken by the government to promote the pharmaceutical sector in
India are as follows:

The Government of India plans to set up around eight mini drug-testing laboratories
across major ports and airports in the country, which is expected to improve the drug
regulatory system and infrastructure facilities by monitoring the standards of imported
and exported drugs and reduce the overall time spent on quality assessment.

India is expected to rank among the top five global pharmaceutical innovation hubs by
2020, based on Government of India's decision to allow 50 per cent public funding in the
pharmaceuticals sector through its Public Private Partnership (PPP) model.#

Indian Pharmaceutical Association (IPA), the professional association of pharmaceutical

companies in India, plans to prepare data integrity guidelines which will help to measure
and benchmark the quality of Indian companies with global peers.

The Government of India plans to incentivise bulk drug manufacturers, including both
state-run and private companies, to encourage Make in India programme and reduce
dependence on imports of Active Pharmaceutical Ingredients (API), nearly 85 per cent of
which come from China.

The Department of Pharmaceuticals has set up an inter-ministerial co-ordination

committee, which would periodically review, coordinate and facilitate the resolution of
the issues and constraints faced by the Indian pharmaceutical companies.

The Department of Pharmaceuticals has planned to launch a venture capital fund of Rs

1,000 crore (US$ 149.11 million) to support start-ups in the research and development in
the pharmaceutical and biotech industry.

Road Ahead:

The Indian pharmaceutical market size is expected to grow to US$ 100 billion by 2025, driven
by increasing consumer spending, rapid urbanization, and raising healthcare insurance among

Going forward, better growth in domestic sales would also depend on the ability of companies to
align their product portfolio towards chronic therapies for diseases such as such as
cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

The Indian government has taken many steps to reduce costs and bring down healthcare
expenses. Speedy introduction of generic drugs into the market has remained in focus and is
expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health
programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical

Key Growth Drivers of This Industry

There are various factors, which govern the growth of the medical and healthcare industry. Some
of the key factors are:

Continuous investments in research & development has resulted in increased productivity and
better quality of drugs, medicines, medical instruments, hospital equipment, and other medical
supplies used in medical industry.

Provides employment to large chunk of human population. United States of America has the
largest workforce i.e. one in every 11 US residents employed in the health care business.

Increased costs in the medical treatment in the developed nations have driven patients to migrate
to Asian countries.

Rise in ailments among the ageing population especially in developed nations has led to the
increase in demand of variety of drugs or medicines.

Innovative techniques of drug discovery and drug development, new cures and treatments, gene
testing for insurance, genetic predictions of disease and related issue, human cloning and
reproductive technologies are the other key drivers of the medical industry

Chapter 3

Company profile

Vision and Mission


Every year, 300 million Himalaya products enter the homes of consumers around the world.
With a range of over 300 healthcare and personal care products including brands like Liv.52,
Cystone, and Bonnisan, we touch the lives of millions of customers worldwide, giving them
products that help them lead healthier, enriched lives.

Himalaya's story began way back in 1930. A curious young man riding through the forests of
Burma saw restless elephants being fed the root of a plant, Rauwolfiaserpentine, which helped
pacify them. Fascinated by the plant's effect on elephants, this young man, Mr. M. Manal, the
founder of Himalaya, wanted to scientifically test the herb's properties.

With no money and only a pocketful of dreams, he pawned his mother's jewelry to buy a hand-
operated tableting machine. The years that followed were a time of endurance and a test of the
young man's patience, strength and passion. He spent his days learning about herbs from
neighborhood healers and his nights working on the machine to make a few hundred tablets. His
vision was to 'bring the traditional Indian science of Ayurveda to society in a contemporary

In a time when herbal products were regarded with skepticism, our founder's belief in the healing
power of herbs was unwavering. He felt that if people were offered safe and effective herbal
medicines, they would come to accept them as part of their healthcare routine. He believed that
herbal medicines could and should be evaluated on the same quality and efficacy parameters as
conventional medicine. This was possible through empirical research. Once scientific research
proved that herbal products worked, even doctors could be won over. This was a big dream with
big challenges. But he persevered on despite the obstacles.

After four years of researching the herb Rauwolfiaserpentine, Serpina, the world's first natural
antihypertensive drug was launched in 1934.

The discovery set the future course for Himalaya. It taught us the value of scientific research. It
also taught us the importance of patience, passion and perseverance. We have since focused on
converting Ayurveda's herbal tradition into a range of proprietary formulations dedicated to
healthy living and longevity.With a history spanning eight decades in the area of herbal research,
Himalaya shares a close relationship with nature. We are in the business of not only promoting
good health but also safeguarding the health of our planet. Ever since our inception, we have
taken great care to protect biodiversity, collect herbs in a sustainable way and promote good
agricultural practices.In 1955, Himalaya introduced Liv. 52, a liver formulation that ensures
optimum liver function. The product soon became our flagship brand and a top selling herbal
medicine. Other brands soon followed including Cystone, Bonnisan and Rumalaya forte,
products that went on to become household names.In 1999, Himalaya entered the personal care
segment under the brand name 'AyurvedaConcepts. This was unchartered territory which
brought with it new challenges and new opportunities for learning. People around the world were
waking up to the benefits of herbal and natural products for their personal care needs. Himalaya
had close to seven decades of research experience in herbal medicine and this legacy had helped
us understand the world of herbs. The prospect of entering the personal care space was therefore
exciting. We wanted to give customers herbal personal care products that were mild, gentle, and
hard-working and steeped in science! Our guiding philosophy was to develop a range of personal
care products rooted inAyurveda and backed by research, a mainstay of the Himalaya brand. By
remaining true to our research ethic, we built credibility for our range of herbal personal care

products and gained the trust of our customers. A year later, we expanded our portfolio to include
animal health products with the objective of caring for the health and well-being of animals.

With our expanding range of products and growth in international markets, Himalaya underwent
a rebranding where the entire range was brought under a single umbrella- Himalaya Herbal
Healthcare. With the present portfolio of pharmaceuticals, personal care, baby care, well-being
and animal health products, Himalaya has evolved into a 'head-to-heel' herbal wellness company.

After close to 80 years, we remain committed to enriching the lives of people who use our
products. Himalaya's therapeutic products have brought relief to people suffering from ailments
like liver disorders, diabetes to kidney stones and joint disabilities. Our personal care range
captures the best in nature and science, giving our customers products that are gentle, effective
and safe for long-term use. Our vision is to offer wellness in every home and for the whole
family through our herbal healthcare and personal care products.

Today, the Himalaya brand is synonymous with safe and efficacious herbal products. Starting off
operations in Dehradun way back in the 1930s, the company later spread its wings to Mumbai
and across the country. In 1975, the company set up an advanced manufacturing facility in
Makali, Bangalore, India. In 1991, the company relocated its R&D facility to Bangalore.

We operate in over 90 countries, our products are prescribed by 400,000 doctors worldwide, and
millions of customers trust us for their health and personal care needs. Himalaya Global
Holdings Ltd. (HGH) is the parent of all Himalaya subsidiaries

Inspired by Ayurveda, Himalaya's originating from the two Sanskrit words, ayes (life) and Veda
(science), Ayurveda is an ancient healing system originating in the Indian subcontinent that relies
on herbs for maintaining good health. Historical records suggest that the journey of Ayurveda
began in India more than 5,000 years ago, and this traditional system of healing has influenced
both Unani humor therapy conceptualized by Hippocrates and ancient Chinese remedies.

The science and practice of Ayurveda are narrated in ancient texts, of which the CharkaSamhita
is the principal resource. The CharkaSamhita refers to a large collection of Hindu sacred texts
called the Vedas. Written in the Indus Valley area around 1000 BC in Sanskrit, the
CharkaSamhita is a treatise on general medicine. This strongly suggests the probability that

Ayurveda, though of pan Indo-European origins, had begun to evolve into a distinct entity within
the Indian subcontinent by the first millennium BC.

Vedic philosophy believes that human beings are all a part of nature. Just as animals and plants
are interdependent on each other to create balance within their beings, there is a concurrent and
inherent connection between the universe and human beings. Unlike the animal kingdom, human
beings live in a more complex, natural world where they are perpetually exposed to
environmental changes. Changes in weather, society, economy, lifestyle, diet, work, financial
status, emotions and relationships can easily tip the balance and negatively influence an
individual's state of mind, body and soul.

According to Ayurveda texts, the human body comprises three body states which include Vata,
Pitta and Kapha. Vata consists of the elements air and ether, which give us movement and
activity. Pitta includes the elements fire and water, which are responsible for heat, appetite and
digestion, and Kapha is characterized by the elements earth and water, which are responsible for
water and other bodily fluids. When the three body states are in perfect harmony, the individual
enjoys good health, whereas an imbalance in the states causes disease. Ayurveda seeks to address
this state of imbalance through a process of holistic healing.

Herbs are at the heart of Ayurveda medication. Whole flowers, roots, stems and leaves are
manually processed in various ways to discover their optimal potential. Over 15,000 herbs are
mentioned in the scriptures of which only around 850 are commonly used in Ayurvedic medicine
today. One of the most commonly used herbs in Ayurveda is Neem. Described as
sarvaroganivarini or that which keeps all diseases at bay, Neem supports the body's natural
defense system. Apart from Neem, Ginger, Amla and Ashvagandha, among others, feature highly
in the list of important plants in this traditional medicinal system.

Historical records suggest that Ayurvedic medicine has paved the way for various branches of
medicine practiced today. SusrutaSamhita, another revered Ayurvedic text, mentions nine
branches in Ayurveda-general medicine, surgery, ear, nose and throat (ENT) and eye disease,
toxicology, psychiatry, pediatrics, gynecology, sexology and virility. Some texts also reveal that
ancient natural healers delved into plastic surgery.

Drawing from this incredible history, Himalaya's mission is to contemporize Ayurveda and
develop safe and effective products to improve quality of life.armaceutical range, promoted
exclusively through doctors, addresses multiple health conditions .Our 60 strong product
portfolio includes therapeutics, wellness products, prescription dermaceuticals and oral health
products for men, women and children. The information in this section is not intended to be a
substitute for professional medical advice. We urge you not to use the same to diagnose or treat
your problem.

Our phytopharmaceutials address lifestyle disorders, chronic illnesses like diabetes and
osteoporosis and life-threatening diseases like Hepatitis B. Our complete range of preventative
care products enhance immunity and assist in the management of health. Derived from herbs,
each product is backed by eight to ten years of research, undergoing clinical trials, mutagen
studies and toxicity tests to ensure safety and efficacy.

Today, Himalaya is ranked thirty-one amongst 500 top pharmaceutical companies in India. Our
brands, Liv.52, Cystone, Bonnisan and Septilin are leaders in their categories. In fact, Liv.52, a
hepato-protective, is the only herbal medicine to be ranked amongst the top ten bestselling
medicines in the country. Care for the environmentpracticing what we preach

Himalaya has received the ISO 14001:2004 certification, the most recognized global standard for
excellence in environmental management.

By setting up a water treatment plant and sourcing water with low total dissolved solid (TDS)
levels, we have reduced water consumption by as much as 17,000 liters a day.

The energy-efficient design of our warehouse allows for maximum natural light and saves
approximately 120,000 units of energy per year.By switching to compact fluorescent lamp (CFL)
and light emitting diode (LED) lights at our facility in Bangalore, we now save over 91.69
kilowatts per hour of energy each year.

These simple but crucial energy saving initiatives have helped us reduce our carbon emissions by
128,366 kilograms thus far.

Harvesting a good rain:

Since the year 2000, Himalaya has been harvesting Rainwater at our Bangalore campus to
conserve water.A well-designed network of eight waterwells and 59 recharge pits ensures that
rainwater is collected effectively. The network of percolation pits and well operates at 90 percent
efficiency and has a combined storage capacity of 90,000 liters. Presently, our entire water
requirement is met by two waterwells with an average generation capacity of 250,000 liters per

Rainwater harvesting has helped increase the water table of the surrounding area, reduced the
scarcity of water during the summer months and decreased the TDS content in the groundwater.
High TDS levels leave water unfit for human consumption and damage crops. The TDS levels in
the area surrounding our campus in Bangalore have reduced from approximately 4,000 parts per
million (ppm) in 2008 to 2,150 ppm in 2012.

Greening our stores:

Himalaya has over 170 exclusive retail outlets across India. We are on a mission to convert our
outlets to eco-stores by using environment friendly materials and reducing our carbon footprint.

Every little step helps our planet:

As part of our Greening the Store initiative, we are consciously choosing materials which are
better for the environment.We have installed energy-efficient CFL lights that consume 75 percent
less energy and last up to ten times longer than incandescent bulbs.
The zero volatile organic compound (VOC) paints used in our stores are non-toxic and do not
deplete the ozone layer. The paint is sourced locally, which means less transportation and a
reduced carbon footprint.
Our carry bags are made from 75 percent recycled paper.Display units within the stores are made
from medium density fiberboard (MDF), which is produced from wood waste and wood

Packing a greener punch:

To make greener products, Himalaya has reduced the amount of packaging materials used so less
waste is generated. In addition, we have transitioned to greener packing materials.
We have redesigned our tertiary packaging, significantly reducing paper and plastic film. A
simple tweak in design resulting in more efficient use of space has meant a 15 percent reduction
in packing materials.

Our hair oils come in bottles made from polyethylene terephthalate (PET), a 100 percent
recyclable material. For our toothpaste and soap cartons, we make use of board procured from
renewable sources. This paper comes from trees planted as part of social forestry projects. We
also use non-toxic soy ink for printing on our soap sleeves.

No waste in our backyard:

In the past ten years, we have improved our waste management process. All types of waste
generated at our facility in Bangalore are properly segregated and systematically handled. Today,
we are recycling 90 percent of our solid waste, 100 percent of our liquid waste and scientifically
disposing of our hazardous waste.

The paper, plastic and other recyclable waste is handed over to certified recyclers. We have set
up an effluent treatment plant that processes liquid waste. The treated effluent is used for
gardening and irrigation of our 10 acre green belt on campus in Bangalore, where we have
planted 600 coconut trees and 3,500 golden bamboo, Napier and lemongrass trees. We are a
certified zero discharge facility

The Himalaya Logo

The Himalaya brand has much in common with the mountain range from which it draws its
name. For centuries, the Himalayas have been an icon of aspiration and of man's quest to unlock
nature's secrets. They represent purity and lofty ideals.

Our logo is a visual definition of our brand identity. The leaf that forms the crossbar of the letter
H represents the company's focus on herbal healthcare. The teal green reflects our closeness to
nature, while the orange is evocative of warmth, vibrancy and our commitment to caring.

The Himalaya brand represents wellness, both internal and topical. Our range of head-to-toe
healthcare and personal care products spans the entire wellness spectrum, offering gentle, safe
and efficacious care. Each and every product that carries our logo is backed by the high quality
that is Himalaya's hallmark. It promises good health, well-being and a prescription for good
living. Our logo symbolizes a promise delivered.Himalaya's mission is to make herbal wellness a
part of every home. We want to be the most trusted company in scientific herbal healthcare and
most admired for our ethics, values and commitment to sustainability.


To bring 'Ayurveda - the source of natural medication', to the society in a modern-day form and
to untangle the mystery behind the 5000 year old system of medicine.

Develop markets worldwide with an in-depth and long-term approach
Maintaining at each step the highest ethical standards.
Respect, collaborate with and utilize the talents of each member of the Himalaya family
and the local communities where Himalaya products are developed.
To remain eco-friendly with the nature.
Ensure that each Himalaya employee strongly backs the Himalaya promise to maintain
good relationship with the costumer.

Our Mission Statement Reads:

Establish Himalaya as a science-based, problem-solving, head-to-heel brand, harnessed

from nature's wealth and characterized by trust and healthy lives.

Develop markets worldwide with an in-depth and long-term approach, maintaining at

each step the highest ethical standards.

Respect, collaborate with and utilize the talents of each member of the Himalaya family
and the local communities where Himalaya products are developed and/or consumed, to

drive our seed-to-shelf policy and to rigorously adopt ecofriendly practices to support the
environment we inhabit.

Ensure that each Himalaya employee strongly backs the Himalaya promise to exceed the
expectations of the consumer, each time and every time. Nothing less is acceptable.

At the heart of the Himalaya mission is the belief that good health should be accessible to
everyone, and we strive to make this possible through our commitment to science-driven
herbal healthcare.

What We Believe In

Life at Himalaya is about being committed to integrity, accountability, fairness,

transparency and innovation.

Integrity: We value the trust our customers, business partners and other stakeholders
have placed in us. By being truthful, consistent and honest in everything we do, we honor
this trust.
Accountability: We are accountable both internally to our team and externally to our
stakeholders. Systems and processes help us ensure accountability at every step.

Fairness: We remain firmly committed to our rules and are guided by our ethics. This
helps us make impartial decisions and treat all parties fairly.
Transparency: Being open in our dealings is integral to our work ethic. Whether it is
interacting with farmers who grow our herbs, vendors who supply us materials or
customers who buy our products, we believe that transparency helps us make partners for

Innovation: Bringing ideas out of the lab and into the real world is the kind of innovation
we pursue. It inspires us to discover new medicines and develop new products that go
onto make life healthier and happier for people.

Himalaya's founder firmly believed that the success of an organization depended on the
quality of its people. The best minds produce the best results. His belief was to hire
bright, passionate individuals who were ready to take on challenges and think 'out of the
box'. By remaining true to this philosophy, we have grown as an organization and
continued to spearhead pioneering research in the herbal space.
Today, we are a family of over 5,000 employees worldwide, including a team of over 200
passionate and energetic research scientists! Years before the 'equal opportunity' mantra
became popular in industry, we have practiced and promoted non-discrimination. In fact,
way back in 1950 our research department was headed by a woman! Today, women make
up 24% of our management staff. We continue to attract people who are talented, driven
and inspired by our vision to bring health and wellness to the lives of the people we
People are Himalaya's most important asset and investing in them is vital to us. From
giving them the creative freedom to push the boundaries of research to fostering a culture
of open communication and diversity, we believe that our nurturing work environment
brings out the best in our team and allows us to develop the best products. Each and every
Himalaya employee is unique and contributes to the success of the organization. All of us
are committed to making a difference.
We believe that the best results come about only when you wake up each morning feeling
excited about your work! In our area of business, where years of research can sometimes

produce no results, staying motivated comes from one's passion for their work. It is the
passion of our people that has given Himalaya a distinctive edge.
Our founder maintained that when you discover people with pure talent and passion, you
should 'create' a job for them. He believed that it is the people with vision and passion
who drive the success of an organization.


Human resource strategies

Market strategies

Financial strategies

Human Resource Strategies:

HR Policies and Procedures

This handbook is intended to provide with a general understanding of our basic Human resource
policies. You are encouraged to familiarize yourself with our policies, as they will answer many
questions concerning your employment with us. Himalayan smile HR Policies cannot anticipate
every situation or answer every question about employment. They are an employment contract
and are not intended to create contractual obligations of any kind. Neither the employee nor the
company is bound to continue the employment relationship if either chooses, as its will, to end
the relationship at any time.

In order to retain necessary flexibility in the administration of policies and procedures, the
company reserves the right to change, revise, or eliminate any of the policies and/or benefits
described in this handbook at any time.
Probationary Period
The probationary period is intended to give new employees the opportunity to demonstrate their
ability to achieve a satisfactory level of performance and to determine whether the new position
meets their performance. The company uses this period to evaluate employee capabilities, work

habits and overall performance. Either the employee or the company may end the employment
relationship at will at any time during probationary period, with or without cause or advance

New employees work on a probationary basis of the first 90 calendar days after their date of hire.
Any significant absence will automatically extend a probationary period by the length of the
absence. If the company determines that the designated probationary period does not allow
sufficient time to thoroughly evaluate the employees performance, the probationary period may
be extended for a specified period.
Performance Evaluations and Compensation
Performance evaluations are conducted at the end of an employees probationary period, to
discuss job responsibilities, standards, and performance requirements. Additional formal
performance reviews are conducted to provide both the company and employees the opportunity
to discuss job tasks, identify and correct performance deficiencies, encourage and recognize
strengths, and
The performance of all employees is generally evaluated according to an ongoing 12-month

Merit-based pay adjustments may be given to recognize truly superior performance and shall be
at the sole discretion of the company.
Employees who have passed their probationary period are provided the following benefits. A
number of the programs (such as Social security, workers compensation, employment provident
fund and employment insurance) cover all employees in the manner.
Company will proved Saturday day off, and off course public holiday (government holiday)
provided by government of Nepal. This includes all festival holiday and other official holiday.
Accept the public holiday member will also receive sick leave. Sick time-off may be either paid
or unpaid and will be granted solely at the discretion of the company. Sick leave is not automatic
and will be granted only when absences are due to personal, legitimate illness or injury. Sick
leave cannot be used for work related injuriesthose are handled under Workers Compensation
state laws.

If an employee is absent for three or more consecutive days due to illness or injury, a physicians
statement may be requested verifying the disability and its beginning and expected ending dates.

Such verification may be requested for other sick leave absences as well and may be required as
a condition to receiving sick leave benefits.
Vacation time-off with pay is available to employees to provide opportunities for rest, relaxation,
and personal pursuits. The amount will not give in name of vacation expenses but no salary will
deduct in this period. Employee will get salary amount while in their vacation time. And the
period will be 15 to 25 day in an each calendar year.
Since employment with the company is based on mutual consent, both the employee and the
company have the right to terminate employment at will, with or without cause, at any time.
Employees will receive their final pay in accordance with applicable state law. So each and every
employee must follow the rule of disciplinary and misconduct.

Termination action will be taken under the company Disciplinary rule and procedure for
conduct Here all example and procedure are explained with action taken on particular
misconduct as well.
Use of Company Computers/Property
It is each employees responsibility to safeguard proprietary company information. Never give
your User ID or Password to anyone. Employees are expected to exit and log off all systems at
the end of every business day or when a workstation is left unattended for an extended period of
It is forbidden to copy or install any illegal software onto company computers.

The company provides access to Electronic Mail and the Internet as business tools. These
facilities represent considerable commitment of company resources for telecommunications,
networking, software, storage, etc. The company policies apply to your conduct when sending
and receiving electronic mail and accessing websites through the Internet. The display of any
kind of sexually explicit image or document on any company system is a violation of our policy
on sexual harassment. In addition, sexually explicit material may not be archived, stored, or
distributed using company-owned computing resources. If you receive an inappropriate
electronic mail, you should delete it immediately and notify the sender of our policy.

Telephones The telephone system records telephone numbers dialed from each telephone, and
the system allows the company to access voicemail messages received by employees.

The company reserves the right to retrieve, monitor, or review any information in its electronic
or communications systems, including deleted messages or files as allowed by federal and state
laws. If the company reasonably believe that employee(s) is/are engaged in illegal activity or

misconduct, the company may use special monitoring to produce evidence of that activity,
without prior notice to the employee(s).
The protection of confidential business information and trade secrets is vital to the interests and
the success of the company. Such confidential information includes, but is not limited to, the
following examples:

Customer lists

Marketing strategies

Financial information

New materials research

Research and development strategies

Proprietary product processes

Technological data

Technological prototypes
Employees who are exposed to confidential information may be required to sign a non-disclosure
agreement as a condition of employment. Any employee who discloses trade secrets or
confidential business information will be subject to disciplinary action, even if he or she does not
actually benefit from the disclosed information.

Himalaya Drug Company's Executive Director, Research and Technical Services, Dr. S K Mitra
said, "Himalaya is delighted to receive ISO 9001: 2000 certification, a quality standard that is
recognized and respected worldwide, and the most prestigious third party recognition of our
long-standing commitment to excellence and leadership in quality management for herbal health

The ISO 9001: 2000 certification is the most comprehensive evidence that a company has
instituted management systems that meet international standards of quality. The ISO 9001
standards cover the quality systems from design through production to servicing at the
customer's site. However, ISO 9001: 2000 certification is not a "lifetime guarantee." Every six
months, certification is renewed based on stringent ISO criteria and reviewed by a team of
independent auditors that the company's processes adhere to ISO guidelines.

When asked to comment on the certification, Himalaya USA President and COO Joe Chimbel
said, "In the context of the proposed GMP regulations in the USA, the twin GMP certifications
by ISO and by the Indian Ministry of Health go much further than any other third party
certification option currently offered in the USA. Along with the scientific evidence of safety and
efficacy generated on every Himalaya product, these quality certifications offer consumers the
highest possible guarantee of performance." Located in Geneva, Switzerland, ISO was created
to promote standards development and facilitate international exchange of goods and services.
More than 90 countries including the United States belong to the ISO.

Marketing strategies:

Brand Identity:
The Himalaya brand has much in common with the mountain range from which it draws its
For centuries, the Himalayas have been an icon of aspiration, of man's quest to unlock Nature's
secrets. They represent purity and lofty ideals.
The Himalaya logo is a visual definition of its brand identity. The leaf that forms the crossbar of
the letter H evokes the company's focus on herbal healthcare
The teal green represents proximity to nature, while the orange is evocative of warmth, vibrancy
and commitment to caring.
The Himalaya brand carries with it the promise of good health and well-being.

Market Needs:
Market needs are high. Because of consciousness of the people or in other words it is need of the
people.so lots of scope for us.

Pestel Analysis:

Economic Factors:
Our decisions will be greatly affected by economic factors. If during introduction of our product
there is negative inflation rate then there will be negative impact on the product sales.


Distribution Strategy:
Convenience stores and large retail stores, many food stores played a key role in the distribution
of oral health care products.
Mass merchandisers also gained share due to increase in the demand for oral care products.
We will create high distribution so that retail and grocery stores are shelving with our product.

Communication Strategy:

In promotion first includes creating awareness of our product
Awareness will be created by television adds, magazines ,newspapers, pamphlets.
Also free samples will be given to the target costumers to check the quality of our product.

Promotional mix:
We are supposed to follow the following steps for the promotional mix:
Mass merchandisers also gained share due to increase in the demand for oral care products.
We will create high distribution so that retail and grocery stores are shelving with our product.

Communication Strategy:


Personal selling

Public relations

Sales promotion

Direct marketing


Himalaya's history is one of innovation through research. Our quest to produce natural, safe and
effective remedies has been driven by several factors: an enduring belief in the power of
ayurveda, a close observation of nature and the systematic application of primary research
methods for validation and testing. We believe that the ideal healthcare system lies in the synergy
between Ayurveda and modern science. It will be our constant endeavor to create innovative
products that satisfy the health and personal care requirements of contemporary living. How we
arrived at many of our best known products makes for interesting reading. Explore this section to
discover these stories...This company takes care of 90 compmanies.

Each and every product that carries our logo is backed by the high quality that is Himalaya's
hallmark. It promises good health, well-being and a prescription for good living. Our logo
symbolizes a promise delivered.

Himalaya's mission is to make herbal wellness a part of every home. We want to be the most
trusted company in scientific herbal healthcare and most admired for our ethics, values and
commitment to sustainability.

Research and Development Center

Himalaya has invested in a state-of-the-art Research & Development (R&D) center in

Bengaluru, India, which encompasses over 80,000 square feet of space. The center is ISO-9001:
2008 certified.

We have a team of more than 200 physicians and scientists working in our R&D facility. Our
scientists come from disciplines as diverse as analytical chemistry, formulation and development,
phytochemistry, new drug discovery, novel drug delivery systems, pharmacognosy, preclinical

toxicology and pharmacology, invitromutagenicity, clinical pharmacology and agriculture. This
vast and diverse background of the R&D team gives us unique insights into the world of herbs,
helping us understand, discover and develop breakthrough products.

The use of advanced technology ensures accuracy, efficacy and safety of each and every product.
For example, we use the liquid chromatography-mass spectrometry (LCMS) method during herb
testing. LCMS separates each molecule from a given extract and helps identify its chemical
nature. This technology is used in the specific detection and potential identification of chemicals
in the presence of other chemicals in a complex mixture. The advantage of using LCMS lies in
the fact that it is an extremely accurate method of analyzing the total marker profile of a given
extract. The technology helps our scientists to standardize all compounds in a given herbal
extract before the product is developed.

In March 2001, we were granted a Good Manufacturing Practices (GMP) certificate, issued by
the Licensing Authority, Directorate of Indian Systems of Medicine, Bengaluru, India. Himalaya
is the first Ayurvedic facility to get GMP certification in India. We have also been granted the
Good Laboratory Practice (GLP) certification. A GLP certification is granted to manufacturing
companies that adhere to the toxicity guidelines in nonclinical safety studies. The certification is
granted by the National Good Laboratory Practice (GLP) Compliance Monitoring Authority,
Department of Science and Technology, Government of India. Only 26 institutions in India have
been granted this certificate, and Himalaya is the first herbal company to have joined ranks with
these institutions.

Himalaya's R&D center is affiliated with one of India's leading universities, The Rajiv Gandhi
Institute of Health Sciences in Bengaluru, and is recognized as a Center for Research by the
Government of India's Department of Science and Technology. We work closely with the
University of Agricultural Sciences in Bengaluru to develop new therapeutic drugs, build a
corpus of knowledge on herbs and protect endangered herbs and plants.

We have partnered with the Ras Al Khaima Medical Health & Science University, a leading
university in the United Arab Emirates, to promote joint research collaboration in herbal

medicine including clinical trials, joint conferences, faculty and student exchange programs, and
joint research and publications.

The R&D Center is a vital institution of higher learning. Several PhD students from universities
across India conduct their research at our center under the supervision of Himalaya scientists.
This is a great opportunity for us to engage with bright minds of the future and be inspired by
their ideas and enthusiasm

New Research Areas

At Himalaya, our scientists are conducting exciting research in the field of oncology, AIDS,
lifestyle related disorders and women's health.

Himalaya's anti-cancer drug project has been underway for the past eight years. Cancer is a result
of abnormal cell growth in the body, and once detected, various chemical drugs are administered
to stop or eliminate the cell growth. However, these drugs come with a host of side effects, which
include nausea, lethargy and hair loss. Herbs have been under the scanner in various research
institutes internationally to find an alternative solution for the disease. Globally, Turmeric's
principal constituent, curcumin, has been extensively studied by Western researchers and
scientists for its antioxidant activity. Researchers continue to study curcumin in relation to
normal cell growth ('Common Indian Spice Stirs Hope', Wall Street Journal, 2005).

At Himalaya, researchers have been testing different herbal extracts to find the one that can stop
the spread of cancer with no side effects. Our team is developing a drug that will either work as
an adjuvant to already available cancer therapies, or be prescribed as a first line of treatment.
While the effectiveness of the drug may be at par with conventional medicine, the focus is on
developing a herbal solution formulation that is safe and free from side effects. Our formulations
are currently being tested on cell lines.

We have also been working on developing an immunomodulation for the past nine years. Herbs
are made of many compounds. Rigorous research has been performed to discover the most
efficacious and safe chemical active in the herb which will stimulate the immune system. Our
formulation has now reached the clinical trial stage.

Diapason is Himalaya's current offering for diabetes. Studies have shown that the drug is known
to lower blood sugar levels in insulin-dependent diabetes mellitus (IDDM) and
non-insulin-dependent diabetes mellitus (NIDDM) patients. When prescribed as an adjuvant, it
reduces the dosage of oral hypoglycemic agents (OHAs) by 30-50% and that of insulin by 20-
30%. Diapason is prescribed by many doctors as a first line of treatment for diabetes. Our R&D
team is currently researching formulations to address secondary diabetes-related complications in
areas of neuropathy, nephropathy and retinal complications.

Psoriasis is another medical condition for which formulations are currently being clinically
tested. It is a chronic, noncontagious autoimmune disease that affects the skin and joints. The
team at Himalaya has been working for the past three years to find a remedy for the disease.

Over 250 plants have been screened to identify herbs or a composition of herbs that possess all
the therapeutic properties required to treat the disease. A unique herbal composition has shown
positive results on cell lines. During the next phase of testing, this new herbal composition will
pass through stringent efficacy trials in order to arrive at successful topical and oral treatment
options for psoriasis.

In the past year, our researchers have discovered potential herbs for the prevention and treatment
of various conditions. The team is working on drugs for malaria, women's health, the herpes
simplex virus (HSV) and HIV. The research for these conditions is at various preclinical stages.
Some compositions are being tested on cell lines and others are still being researched to extract
maximum therapeutic benefits.

At Himalaya, we place the utmost importance on research. Often, our scientists recall moments
during research when testing a particular herb for one medical condition paved the way for
another! Himplasia, our product for Benign Prostrate Hyperplasia (BPH), came about due to one
such accidental discovery. The success of Himalaya is our ability to deliver effective, novel
drugs, and research is the only way to get there!

Privacy Policy

At The Himalaya Drug Company, we respect every individual's right to privacy. Our relationship
with you is our most valuable asset and is the very basis of our name and reputation.

We understand the importance you place on the privacy and security of information that
personally identifies you or your account information. We refer to and treat this information as
"personal information".

We do reserve the right to disclose or report personal information in limited circumstances where
we believe in good faith that disclosure is required under law, to co-operate with regulators or
law enforcement authorities, or to protect our rights or property.

We use personal information in ways that are compatible with the purposes for which we
originally requested it. For example, we will use the information you give us to process your

requests and transactions, to provide you with additional information about products and
services, or to evaluate your financial needs. To do so, we may share personal information with
an agent or affiliate.

We limit the collection and use of personal information to what is necessary to administer our
business and to deliver superior service to you. This may include advising you about our
products or services, those of our affiliates, and other opportunities that we believe may interest
you. To serve you better, we may combine information you give us on the Web or through other

When we share personal information with an agent or affiliate, we protect that personal
information with a strict confidentiality agreement. Companies that we hire to provide support
services or act as our agent must conform to our privacy standards.

Himalaya corporate policies require that employees with access to confidential customer
information may not use or disclose the information except for business use. All employees are
required to safeguard such information, as specified in their confidentiality agreements with

On occasions, we may assist a company that is not affiliated with Himalaya in providing or
offering a product or service to you. In such circumstances, marketing materials will include
instructions on how you can request not to receive those communications in the future. In all
cases, your personal information is protected by a strict confidentiality agreement. We do not
allow any nonaffiliated company to retain your personal information longer than necessary to
provide the product, service, or information, unless you affirmatively grant us permission to do

We continue to evaluate our efforts to protect personal information and make every effort to keep
your personal information accurate and up to date.

If you identify any error in your personal information or need to make a change to that
information, please contact us and we will promptly update our records.

SWOT analysis of Himalaya Drug


Strong financial back up

Qualified staff.

Providing our customers what they want.

Targeting both urban and rural markets.

Eco friendly herbal product.

Use of natural fluoride in place of fluoride used up by other companies.


High investment and growth.

Growth will occur because of ecofriendly toothpaste.

As it is a daily usable commodity so company is using intensive distribution technology

So that it will available at every shop due to which sales of company's product will be
increased day by day.

As the world is becoming a global village so company had also opportunities to grow


As the company is entering into new market and launching a new product so there is
always chances of failure of the product.

Company have to face a lots and lots of competition from the competitors already present
the market.

It is an Ayurveda product and there are so many international companies present in the
market so it is threat for the company.


Due to high price of the product it may be unaffordable for people of rural areas to pay
for the product.

Ayurveda product.

Gaint competitors in the market like colgate,pepsodent that are already establish in the


Findings/Suggestions & Conclusion

Himalaya Drug Company Major Findings:

1. The Himalaya drug company have the high growth rate.

2. Himalaya Drug Company provides Eco friendly products.

3. It targets both urban and rural market

4.Due to high price of the product it may be unaffordable for people of rural areas to pay for the

5. 98% of retailers deals with Himalaya products


1. Himalaya should organize campaign for general awareness of endconsumer.

2. Himalaya should also target market in remote areas.
3. Himalaya should organize free medical checkup camps over fixed duration of time .This
will help in the fulfillment of corporate social responsibility. This will also help in
creating a brand image in the consumer mind.
4. Most of the Himalayan products with in the Age of 61 & above with a share of 35%.

5. Himalaya should also get opportunity in the general medicines, fever, pain etc. people
having in Ayurveda will get good option for themselves and also have a great consumer

Himalaya Drug Company is the oldest Ayurvedic drug manufacturing company in the India.it
deals in both pharma and FMCG .In the available pharama range Himalaya is one of the reputed

Himalaya mainly beliefs in engage ethical promotions to the doctor.it also executive to the
motivate doctor requirement turn of prescribing of Himalaya.During the meeting they also
aware about the competitors promotional strategy and product availability under the brand.

Chemist who deals with the Himalaya herbals are highly satisfied with the business of Himalaya.
According to the chemist the customer who are consuming Himalaya are satisfied with the

Although it is Ayurvedic medicines are slow at their work but theare effective for long time.

Finally my project says that the pattern of job performance and quality of the product is highly
appreciated by the consumer .




S. No Particulars Page No

1 Introduction to Company 1

2 Need for the Study 2

3 Scope of the Study 3

4 Objective of the Study 4

5 Methodology of the Study 5

6 Limitations of the Study 6

7 Industry Profile 7-12

8 Company Profile 13-24

9 Findings

10 Suggestions

11 References

12 Conclusion